-
Je něco špatně v tomto záznamu ?
Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells
H. Kovaru, M. Pav, F. Kovaru, J. Raboch, A. Fiserova
Jazyk angličtina Země Švédsko
Typ dokumentu práce podpořená grantem, přehledy
PubMed
20010506
Knihovny.cz E-zdroje
- MeSH
- antidepresiva terapeutické užití MeSH
- buňky NK imunologie metabolismus účinky léků MeSH
- centrální nervový systém cytologie imunologie MeSH
- depresivní poruchy farmakoterapie imunologie MeSH
- lidé MeSH
- neuroglie imunologie metabolismus účinky léků MeSH
- signální transdukce imunologie účinky léků MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
- přehledy MeSH
CNS, endocrine and immune systems share the same molecules: neurotransmitters, cytokines and hormones to communicate within and among each other. Depression is associated with abnormalities in the noradrenergic, serotonergic and dopaminergic neurotransmitter systems and reductions in the level of their precursors and metabolic turnover. Most of these signalling molecules use trimeric G-proteins as a transduction system to transfer extracellular signal into cellular response. Altered levels or function of signalling proteins, especially alpha subunits of trimeric G-proteins, were found in post-mortem brain tissue and leukocytes of subject suffering from major depression. There is a considerable evidence that inflammatory response and immune system changes are the part of depression. Components of cellular immune system natural killer cells, important effectors of immune surveillance, are sensitive to stress response, and their functions are compromised in depressive subjects. Many lines of evidence also point to the loss of both neuronal and glial plasticity and neurotrophic factor support under chronic stress or in depression. There is an increasing knowledge of the role of astrocytic cells in neuroplastic processes and neurotransmitter metabolism. Alterations in the glial populations are observed in major depressive subjects. Antidepressant treatment is modulating glial signalization cascades, increasing production of neurotrophic molecules, supporting neuroplasticity processes, and also modulating functions of natural killers. At the level of membrane signalling, antidepressants show a direct influence upon G alpha subunit levels in both immune system and CNS. These findings support the view that antidepressants influence activity of natural killer and astrocytic populations, and this could be of importance in the depression etiopathogenesis and/or treatment.
Literatura.
- 000
- 03669naa a2200445 a 4500
- 001
- bmc12009081
- 003
- CZ-PrNML
- 005
- 20130403225258.0
- 008
- 120319s2009 sw eng||
- 009
- AR
- 035 __
- $a (PubMed)20010506
- 040 __
- $d ABA008 $a ABA008 $b cze
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Kovářů, Hana, $d 1945- $7 nlk20020124795 $u 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. hkova@lf1.cuni.cz
- 245 10
- $a Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells / $c H. Kovaru, M. Pav, F. Kovaru, J. Raboch, A. Fiserova
- 504 __
- $a Literatura. $b 119
- 520 9_
- $a CNS, endocrine and immune systems share the same molecules: neurotransmitters, cytokines and hormones to communicate within and among each other. Depression is associated with abnormalities in the noradrenergic, serotonergic and dopaminergic neurotransmitter systems and reductions in the level of their precursors and metabolic turnover. Most of these signalling molecules use trimeric G-proteins as a transduction system to transfer extracellular signal into cellular response. Altered levels or function of signalling proteins, especially alpha subunits of trimeric G-proteins, were found in post-mortem brain tissue and leukocytes of subject suffering from major depression. There is a considerable evidence that inflammatory response and immune system changes are the part of depression. Components of cellular immune system natural killer cells, important effectors of immune surveillance, are sensitive to stress response, and their functions are compromised in depressive subjects. Many lines of evidence also point to the loss of both neuronal and glial plasticity and neurotrophic factor support under chronic stress or in depression. There is an increasing knowledge of the role of astrocytic cells in neuroplastic processes and neurotransmitter metabolism. Alterations in the glial populations are observed in major depressive subjects. Antidepressant treatment is modulating glial signalization cascades, increasing production of neurotrophic molecules, supporting neuroplasticity processes, and also modulating functions of natural killers. At the level of membrane signalling, antidepressants show a direct influence upon G alpha subunit levels in both immune system and CNS. These findings support the view that antidepressants influence activity of natural killer and astrocytic populations, and this could be of importance in the depression etiopathogenesis and/or treatment.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a antidepresiva $x terapeutické užití $7 D000928
- 650 02
- $a centrální nervový systém $x cytologie $x imunologie $7 D002490
- 650 02
- $a depresivní poruchy $x farmakoterapie $x imunologie $7 D003866
- 650 02
- $a lidé $7 D006801
- 650 02
- $a buňky NK $x imunologie $x metabolismus $x účinky léků $7 D007694
- 650 02
- $a neuroglie $x imunologie $x metabolismus $x účinky léků $7 D009457
- 650 02
- $a signální transdukce $x imunologie $x účinky léků $7 D015398
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Páv, Marek, $d 1974- $7 xx0093011
- 700 1_
- $a Kovářů, František $7 mzk2005294944
- 700 1_
- $a Raboch, Jiří, $d 1951- $7 jn20000402087
- 700 1_
- $a Fišerová, Anna $7 xx0074790
- 773 0_
- $t Neuroendocrinology Letters $p Neuroendocrinol Lett $g Roč. 30, č. 4 (2009), s. 421-428 $x 0172-780X $w MED00168352
- 773 0_
- $p Neuroendocrinol Lett $g 30(4):421-8, 2009 $x 0172-780X
- 910 __
- $a ABA008 $b x $y 4
- 990 __
- $a 20120319150855 $b ABA008
- 991 __
- $a 20130403225524 $b ABA008
- 999 __
- $a ok $b bmc $g 902305 $s 765987
- BAS __
- $a 3
- BMC __
- $a 2009 $b 30 $c 4 $d 421-428 $i 0172-780X $m Neuro-endocrinology letters $x MED00168352
- LZP __
- $a 2012-1Q10/